ACC GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600057

Contents of this Issue

Navigation

Page 12 of 33

11 Table 7. Acute Treatment of MAT COR LOE Recommendation IIa C-LD IV metoprolol or verapamil can be useful for acute treatment in patients with MAT. Figure 6. Acute Treatment of AVNRT AVNRT YES NO IV beta blockers, IV diltiazem, or IV verapamil (Class IIa) IV amiodarone (Class IIb) Vagal maneuvers and/or IV adenosine (Class I) If ineffective Synchronized cardioversion a (Class I) If ineffective or not feasible If ineffective or not feasible Hemodynamically stable a For rhythms that break or recur spontaneously, synchronized cardioversion is not appropriate. Oral beta blockers, diltiazem, or verapamil may be reasonable for acute treatment in hemodynamically stable patients with AVNRT (Class IIb) Table 8. Ongoing Management of MAT COR LOE Recommendations IIa B-NR Oral verapamil (LOE: B-NR) or diltiazem (LOE: C-LD) is reasonable for ongoing management in patients with recurrent symptomatic MAT. C-LD IIa C-LD Metoprolol is reasonable for ongoing management in patients with recurrent symptomatic MAT. AVNRT

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle (free trial) - Supraventricular Tachycardia